COGNITION THERAPEUTICS
Cognition Therapeutics, Inc. is focused on the discovery and development of small molecule therapeutics targeting the toxic proteins that cause the cognitive decline associated with Alzheimer's disease and other degenerative diseases of the human brain. Toxic proteins play a crucial role in a large class of disease targets, and there are currently no therapeutics available to prevent toxic protein accumulation or block their destructive effects. Cognition is founded on the unique combination of biological expertise around these targets, including proprietary assays that emphasize functional responses and proprietary medicinal chemistry that insures novel, high quality small-molecule drug candidates.
COGNITION THERAPEUTICS
Industry:
Biotechnology Life Science Therapeutics
Founded:
2007-01-01
Address:
Pittsburgh, Pennsylvania, United States
Country:
United States
Website Url:
http://www.cogrx.com
Total Employee:
51+
Status:
Active
Contact:
(412)481-2210
Email Addresses:
[email protected]
Total Funding:
157.49 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Google Universal Analytics Font Awesome Sitelinks Search Box Euro
Similar Organizations
Reflection Therapeutics
Reflection Therapeutics is developing cell therapy technology against neuroinflammation across the board.
InVivo Biosystems
InVivo Biosystems is using alternative, non-mammalian model organisms in early biological and biomedical research.
NeuroNascent
Neuronascent discovers and develops small molecule therapeutics for depression and neurodegenerative diseases.
Nereid Therapeutics
Nereid Therapeutics is discovering new disease treatments by applying research and technologies in biomolecular condensates.
Nuntius Therapeutics
Nuntius Therapeutics is pioneering a new class of targeted RNA, DNA and CRISPR therapies.
Neuroglee Therapeutics
Neuroglee Therapeutics is a digital therapeutic platform created to treat patients in the early stages of the disease.
Nurix Therapeutics
Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.
Veralox Therapeutics
Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes.
Viking Therapeutics
Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders.
Vodori
Vodori provides solutions that simplify how life science companies create, approve, and distribute promotional content.
Via Nova Therapeutics
Via Nova Therapeutics is to discover and develop therapeutics for acute and subacute viral infections.
MitoChem Therapeutics
MitoChem Therapeutics develops treatments to address the effects of mitochondrial dysfunction in neurodegenerative, aging, and disease.
Metabolic Solutions Development
Metabolic Solutions Development develops innovative therapeutics based on a novel pharmacological method to treat type two diabetes.
Mobilion Systems
MOBILion Systems specializes in identifying and analyzing challenging molecules that other instruments so far have failed to detect.
Leyden Labs
Leyden Labs provides a platform that targets commonalities of viral families to protect humanity from known and future viruses.
Lipopharma
Lipopharma is company that designs and develops synthetic bio-active lipids that interact with proteins involved in serious diseases.
LNC Therapeutics
LNC Therapeutics is developing gut microbiota directed drugs to target obesity and associated cardiometabolic diseases.
ABAC Therapeutics
ABAC Therapeutics (ABAC) develops new targeted antibiotics for patients with severe infections.
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Aadi Bioscience
Aadi Bioscience develops a potentially mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases.
Abcam
An innovator in life science reagents and tools serving life science researchers globally to achieve their mission, faster.
Asterias Biotherapeutics
Asterias Biotherapeutics is a development-stage biotechnology company pioneering the field of regenerative medicine.
Acumen Pharmaceuticals
Acumen is developing targeted therapies for the safe and effective treatment of Alzheimer’s Disease and related neurodegenerative diseases.
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
EnGeneIC
EnGeneIC develops and commercializes the treatment of cancer through the targeted delivery of therapeutic agents directly to cancer cells.
electroCore
ElectroCore develops neuromodulation therapies for the non-invasive treatment of diseases and disorders.
Evommune
Evommune is taking a tissue-based approach to advance insights and accelerate the development of transformative medicines.
Epirus Biopharmaceuticals
Epirus Biopharmaceuticals develops biosimilar monoclonal antibodies and therapeutic proteins for emerging markets.
Edesa Biotech
Edesa develops treatments for dermatological and anorectal diseases. Edesa merged with Stellar Biotechnologies in 2019.
Broad Institute
The Broad Institute brings together a diverse group of individuals from across its partner institutions to confront biomedical challenges.
BioAegis Therapeutics
BioAegis is developing therapeutics for infectious, inflammatory and degenerative diseases based on the platform of plasma gelsolin.
Fluidic Analytics
Fluidic Analytics designs, develops and manufactures tools that seek to revolutionise the way proteins are characterised.
Tranquis Therapeutics
Tranquis Therapeutics is focused on the discovery and development of therapies to treat neurodegenerative and aging-related diseases.
TapImmune
TapImmune develops immunotherapeutics to treat cancers, infectious diseases, autoimmune disorders, and transplant tissue rejection.
Think Bioscience
Think Bioscience is reimagining synthetic biology by guiding the design and assembly of better medicines through the use of living systems.
Thrive Bioscience
Thrive sells instruments and software that automate with extensive imaging, analytics, and AI manual and stem cell culture.
T3 Pharmaceuticals
T3 Pharmaceuticals is to improve the lives of cancer patients with highly innovative treatments.
T3D Therapeutics
T3D Therapeutics is a company developing remedial therapeutics for Alzheimer’s disease and other CNS disorders.
Annovis Bio
Annovis Bio develops novel treatments for Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative disorders.
Kyverna Therapeutics
Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases.
Kineta
Kineta aims at developing edge therapeutics in autoimmune disease, viral disease, and chronic pain areas.
Senda Biosciences
Senda Biosciences is a therapeutics platform company leveraging unprecedented insights into the molecular connections between humans.
Signum Biosciences
Signum Biosciences develops small molecule therapeutics derived from its STM platform to modulate signal transduction imbalances.
Sonoma BioTherapeutics
Sonoma BioTherapeutics develops adoptive Treg therapies cell for autoimmune.
Seranova Bio
Seranova Bio develops companion diagnostics or therapeutics to treat autoimmune disease or other autoantibody-driven diseases.
Souvien Therapeutics
Souvien Therapeutics is developing novel therapeutics to modulate critical epigenetic mechanisms associated with neurodegeneration.
SQZ Biotech
SQZ Biotech features a cell engineering technology designed to deliver a diverse set of materials into patient cells.
Sharp Edge Labs
Sharp Edge Labs is engaged in the development of biosensors for cellular biology research and high-throughput screening.
Scioto Biosciences
Scioto is a developer of Activated Bacterial Therapeutics platform.
Hydra Biosciences
Hydra Biosciences develops novel drugs to treat pain, inflammation, cardiovascular and other diseases using ion channels.
Hui-Gene Therapeutics
Hui-Gene is focused on R&D for single-gene disorders and has developed pilot pipes in neurodegenerative diseases.
Immusoft
Immusoft, a biotechnology company, commercializes technologies that program the human immune system by modifying the DNA in related cells.
Immunomic Therapeutics
Immunomic Therapeutics is a development stage biotechnology company that develops lysosomal associated membrane protein-based vaccines.
Iconic Therapeutics
Iconic Therapeutics develops and commercializes immunoconjugate proteins that trigger the immune system to destroy invader cells.
Revolo Biotherapeutics
Revolo Biotherapeutics has developed therapies that achieve superior long-term disease remission from less frequent chronic dosing.
ImCheck Therapeutics
ImCheck Therapeutics is a developing novel therapeutics that target members of the butyrophilin (BTN) super-family of checkpoint molecules.
Intergalactic Therapeutics
Intergalactic Therapeutics is an ATP company, is revolutionizing gene therapies with a novel non-viral platform.
iSpecimen
iSpecimen is the marketplace for human biospecimens, providing researchers with the samples they need from the patients they want.
GlyGenix Therapeutics
GlyGenix Therapeutics develops therapeutic products for the treatment of cure metabolic disorders.
Good Therapeutics
Good Therapeutics develops new technology for self-regulating drugs that will provide a therapeutic activity when, where it is needed.
Galera Therapeutics
Galera Therapeutics develops therapeutic agents for preventing damage to normal tissues during the radiation treatment of cancer.
Gamma Biosciences
Gamma Biosciences is a next-generation bioprocessing for advanced therapies by acquiring or investing in high-potential businesses.
Garuda Therapeutics
Garuda Therapeutics is developing off-the-shelf hematopoietic stem cell (HSC) therapies to treat severe and life-threatening diseases.
Omniome
Omniome engages in developing a proprietary DNA sequencing platform capable of delivering unsurpassed sequencing accuracy.
Oligomerix
Oligomerix develops target identification and validation technologies enhancing the drug discovery process for neurodegenerative diseases.
OnKure Therapeutics
OnKure is a biotechnology company that commercializes a new cancer therapy based on novel, less toxic kinase inhibitor drugs.
Oncoinvent
Oncoinvent develops new radiopharmaceutical products for better treatment options for cancer patients.
Cadent Therapeutics
Cadent Therapeutics develops novel medicines that tune and modulate brain rhythms for patients with serious neurological disease.
Cerevance
Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.
Cardiol Therapeutics
Cardiol Therapeutics develops innovative cannabidiol medicines for heart disease.
Centrillion Technologies
Centrillion Biosciences develops genomics and DNA analyses technology for personalized medicine, life sciences research, and bioinformatics.
Caliber Therapeutics
Caliber Therapeutics offers Targeted Angioplasty Drug Delivery balloon, a stent-free delivery platform of anti-restenotic drugs.
Coya Therapeutics
Coya Therapeutics is a cell therapy platform company that develops first-in-class therapeutics for ALS and other neurodegenerative diseases.
Carmell Therapeutics
Carmell develops technology for producing biologically-active plastics from blood plasma for treating bone and connective tissue injuries.
Creyon Bio
Reinventing drug development from the ground up to make safe, effective oligonucleotide-based medicines possible on demand.
Civetta Therapeutics
Civetta Therapeutics is a cancer therapeutics company to advance new medicines through small molecule targeting of beta-propeller domains.
Corisma
Corisma develops a catheter implanted circulatory assist device designed to treat patients suffering from advanced heart failure.
CoWin Biosciences
CoWin Biosciences provides high-quality biology reagents in life science research and molecular diagnostics field.
Phoenicis
Phoenicis focuses on developing therapies to provide hope and relief to people living with rare disease.
Platelet BioGenesis
Platelet BioGenesis specializes in the fields of biotechnology, platelets, and drug discovery.
Peptilogics
Clinical-stage therapeutics company with a computational deep learning peptide design platform • Design > discovery
PhenoVista Biosciences
PhenoVista Biosciences provides high content imaging-based phenotypic assay development and screening services.
Propellon Therapeutics
Propellon Therapeutics is developing and commercializing novel cancer therapies targeting the WDR5 protein.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
National Institute on Aging
National Institute on Aging investment in Grant - Cognition Therapeutics
National Institute on Aging
National Institute on Aging investment in Grant - Cognition Therapeutics
National Institute on Aging
National Institute on Aging investment in Grant - Cognition Therapeutics
Sofia Fund
Sofia Fund investment in Venture Round - Cognition Therapeutics
Maine Angels
Maine Angels investment in Venture Round - Cognition Therapeutics
Sofia Fund
Sofia Fund investment in Convertible Note - Cognition Therapeutics
Dolby Family Ventures
Dolby Family Ventures investment in Series B - Cognition Therapeutics
Maine Angels
Maine Angels investment in Series B - Cognition Therapeutics
Scale Investors
Scale Investors investment in Series B - Cognition Therapeutics
Tech Coast Angels
Tech Coast Angels investment in Series B - Cognition Therapeutics
Official Site Inspections
http://www.cogrx.com Semrush global rank: 4.64 M Semrush visits lastest month: 2.14 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
